|  |



Medicines for All Institute develops low-cost process to make HIV-prevention medication

Lenacapavir, a long-acting injectable which can prevent and treat infection from the human immunodeficiency virus, could dramatically decrease new HIV ...


View article...


Top stories of the last 30 days